Is cephalexin (a cephalosporin antibiotic) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Cephalexin During Pregnancy

Cephalexin is safe to use during pregnancy and is recommended as a systemic antibiotic option for pregnant patients. 1

Evidence Supporting Safety

Cephalexin belongs to the first-generation cephalosporin class of antibiotics, which are considered safe during pregnancy based on multiple guidelines and FDA information:

  • The FDA classifies cephalexin in Pregnancy Category B, indicating that reproduction studies in animals have revealed no evidence of harm to the fetus, though adequate and well-controlled studies in pregnant women are limited 2
  • According to the 2025 North American Clinical Practice Guidelines for hidradenitis suppurativa, cephalexin is specifically suggested for pregnant patients requiring systemic antibiotics, with moderate quality evidence supporting this recommendation 1
  • Praxis Medical Insights confirms that cephalosporins, including cephalexin, are among the safest antibiotic classes during pregnancy 3

Pharmacokinetics in Pregnancy

Research has demonstrated that cephalexin effectively crosses the placental barrier and reaches adequate levels in amniotic fluid to inhibit common pathogens involved in maternal-fetal infections 4. This makes it an effective choice for treating various infections during pregnancy while maintaining safety for the developing fetus.

Clinical Applications During Pregnancy

Cephalexin is particularly useful for treating the following conditions in pregnant women:

  • Urinary tract infections 5
  • Skin and soft tissue infections
  • Streptococcal infections
  • Hidradenitis suppurativa 1

Dosing Recommendations

The standard dosing for cephalexin during pregnancy is:

  • 500 mg orally every 6 hours for most infections 6
  • Duration depends on the specific infection being treated

Advantages Over Other Antibiotics

Several antibiotics should be avoided during pregnancy, making cephalexin a preferred option:

  • Tetracyclines (including doxycycline) should be avoided due to risks of tooth discoloration and bone growth inhibition 1
  • Fluoroquinolones should be avoided due to potential cartilage damage 1
  • Trimethoprim-sulfamethoxazole should be avoided due to risks of hyperbilirubinemia, fetal hemolytic anemia, and increased risk of preterm birth 1

Potential Side Effects and Monitoring

While generally safe, healthcare providers should be aware of:

  • Potential for gastrointestinal side effects, particularly in patients with history of colitis 2
  • Possible interaction with metformin, requiring careful monitoring and potential dose adjustment 2
  • Rare allergic reactions (though less common than with penicillins)

Special Considerations

  • For patients with penicillin allergy without history of anaphylaxis, cephalexin may still be safely used in most cases 1
  • In patients with severe penicillin allergy (anaphylaxis, angioedema, respiratory distress), alternative antibiotics should be considered 1
  • Cephalexin is also safe during breastfeeding, though it does appear in breast milk at low levels 2

Cephalexin has demonstrated efficacy in various clinical scenarios during pregnancy, including treatment of pyelonephritis 6 and pelvic inflammatory disease 7, with successful pregnancy outcomes following treatment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Use in Pregnant Patients and Pediatric Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A study of the kinetics of cephapirin and cephalexin in pregnancy.

Current medical research and opinion, 1980

Research

Successful pregnancy outcome following first trimester pelvic inflammatory disease.

The Australian & New Zealand journal of obstetrics & gynaecology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.